The segment net income, including significant segment expenses that are regularly reviewed by the CODM, for the three months ended March 31, 2026 and 2025, and the total segment assets as of March 31, 2026 and December 31, 2025, are presented in the tables below (in thousands):


	For the Three Months Ended March 31,
	2026		2025
Cannabis Portfolio Segment:
Rental revenues (including tenant reimbursements)	$	68,920	$	71,697
Other revenues	76		25
Total reportable segment revenue	68,996		71,722
Property expenses	(7,576)		(7,379)
Depreciation and amortization expense	(18,584)		(18,391)
Impairment loss on real estate	—		(3,527)
Gain (loss) on sale of real estate	422		—
Interest and other income	442		600
Cannabis Portfolio Segment net income	43,700		43,025

Life Science Portfolio Segment:
Interest and other income	5,544		—
Life Science Portfolio Segment net income	5,544		—

Total reportable segment net income	49,244		43,025

Unallocated:
General and administrative expense	(10,349)		(8,461)
Interest and other income	345		1,013
Interest expense	(6,431)		(4,500)
Net income	32,809		31,077
Preferred stock dividends	(2,654)		(781)
Net income attributable to common stockholders	$	30,155	$	30,296


Segment Total Assets:	March 31, 2026		December 31, 2025
Cannabis Portfolio Segment	$	2,145,401	$	2,165,359
Life Science Portfolio Segment	153,980		152,665
Unallocated	94,599		52,834
Total	$	2,393,980	$	2,370,858